$0.78
0.00 (0%)
Replidyne, Inc. (RDYN.DL)
CAPS Rating:
The Company is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products.
No one has written a Pitch for RDYN.DL stock yet. Tell us why you think RDYN.DL will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
